Archive for September 2022

The traditional process of patients accepting whichever medication a doctor recommends is starting to disappear. Patients are also learning more about drugs on their own. Companies can dispel misinformation by becoming information brokers themselves, writes a Boston-based CEO of a New York company. Read More

Amylyx Pharmaceuticals Inc. has won its first approval from the U.S. Food and Drug Administration for a drug designed to treat amyotrophic lateral sclerosis, or ALS. Read More

The school will be renamed after one of the university’s former presidents and an alumnus who was an accomplished clarinetist — both of whom grew up together in Rhode Island. Read More

Wu told hundreds of attendees at a Greater Boston Chamber of Commerce event in Back Bay that she wants the city to hit 800,000 residents again, a population level it hasn’t seen since the mid-20th century. Read More

A Harvard Medical School professor has calculated that nonfatal gun injuries have a significant economic cost: $30,000 in direct health care spending per survivor in the first year alone. An estimated 85,000 people in the United States survive a firearm injury every year, and each of them ends up racking up 400% more in health…

Fort Point Capital’s third fund is composed of two separate funds, with one dedicated to investors who are not based in the U.S. Read More

Santander is Massachusetts’ third-largest bank and has been increasing its work in sustainability and green projects. Read More